Alzheimer’s
-
ADRD Prevalence in Various Insurance Populations: A Collaboration with The Alzheimer’s Association
Read more: ADRD Prevalence in Various Insurance Populations: A Collaboration with The Alzheimer’s AssociationAlzheimer’s disease and related dementias (ADRD) represent a significant and growing cost to the United States health care system. While the prevalence and cost of ADRD related to Medicare Fee-for-Service beneficiaries is documented in the Center for Medicare and Medicaid Services’ Chronic Conditions Warehouse, less is known about the prevalence and cost of ADRD among…
-
Examining the adoption of a new Medicare billing code for cognitive assessments: a slow but steady uptake
Read more: Examining the adoption of a new Medicare billing code for cognitive assessments: a slow but steady uptakeOn January 1, 2017, the Medicare program started reimbursing providers for a new procedure code for clinical visits for cognitive assessments and care planning services (CPT code G0505). This newly-billable service is intended to improve the care of patients with Alzheimer’s disease and related dementias and hopefully increase early detection and diagnosis. A G0505 visit…